Volume 51, Issue 11 pp. 1071-1077
Original Article

Comparison of approaches to rheumatic fever surveillance across Organisation for Economic Co-operation and Development countries

Jane Oliver

Corresponding Author

Jane Oliver

Department of Public Health, University of Otago, Wellington, New Zealand

Correspondence: Ms Jane Oliver, Department of Public Health, University of Otago, PO Box 7343, Wellington South 6242, New Zealand. Fax: +64 4 389 5319; email: [email protected]Search for more papers by this author
Michael G Baker

Michael G Baker

Department of Public Health, University of Otago, Wellington, New Zealand

Search for more papers by this author
Nevil Pierse

Nevil Pierse

Department of Public Health, University of Otago, Wellington, New Zealand

Search for more papers by this author
Jonathan Carapetis

Jonathan Carapetis

Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia

Search for more papers by this author
First published: 14 July 2015
Citations: 7
Conflict of interest: The authors have no coflicts of interest to disclose.

Abstract

Aim

Rheumatic fever (RF) prevention, control and surveillance are increasingly important priorities in New Zealand (NZ) and Australia. We compared RF surveillance across Organisation for Economic Co-operation and Development (OECD) member countries to assist in benchmarking and identifying useful approaches.

Methods

A structured literature review was completed using Medline and PubMed databases, investigating RF incidence rates. Surveillance methods were noted. Health department websites were searched to assess whether addressing RF was a Government priority.

Results

Of 32 OECD member countries, nine reported RF incidence rates after 1999. Highest rates were seen in indigenous Australians, and NZ Māori and Pacific peoples. NZ and Australian surveillance systems are highly developed, with notification and register data compiled regularly. Only these two Governments appeared to prioritise RF surveillance and control. Other countries relied mainly on hospitalisation data. There is a lack of standardisation across incidence rate calculations. Israel and Italy may have relatively high RF rates among developed countries.

Conclusions

RF lingers in specific populations in OECD member countries. At a minimum, RF registers are needed in higher incidence countries. Countries with low RF incidences should periodically review surveillance information to ensure rates are not increasing.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.